Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, announced its participation in the 36th Annual Piper Sandler Healthcare Conference in New York. The company's Founder & CEO Sean McClain will join a panel discussion on 'The Promise of AI in Drug Development' scheduled for Thursday, December 5th at 2:00 p.m. Eastern Time. Those interested in attending can request registration details through their Piper Sandler representative.

News Market Reaction – ABSI

-4.85%

-4.85% Session move

In the trading session that priced this news, ABSI declined 4.85%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, Wash. and NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 36^th Annual Piper Sandler Healthcare Conference in New York, NY.

Absci’s Founder & CEO Sean McClain is scheduled to participate in a panel discussion titled “The Promise of AI in Drug Development” on Thursday, December 5^th at 2:00 p.m. Eastern Time.

Interested parties may contact their Piper Sandler representative to request registration details for this live event.

About Absci

Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.

Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com

Media Contact
press@absci.com

FAQ

When is Absci (ABSI) participating in the Piper Sandler Healthcare Conference 2024?

Absci (ABSI) is participating on Thursday, December 5th, 2024, at 2:00 p.m. Eastern Time.

What panel is Absci (ABSI) participating in at the Piper Sandler Healthcare Conference?

Absci's CEO Sean McClain is participating in a panel discussion titled 'The Promise of AI in Drug Development.'

How can investors attend Absci's (ABSI) panel at the Piper Sandler Conference?

Interested parties need to contact their Piper Sandler representative to request registration details for the live event.

Where is the 36th Annual Piper Sandler Healthcare Conference with Absci (ABSI) being held?

The conference is being held in New York, NY.